Granted Patent
B2
US 9,198,949 · App. 14/406,091 · Granted Dec 1, 2015
Method and pharmaceutical composition for use in the treatment of cancer
Inventors:
Santos Susin (Paris, FR); Pierre Launay (Paris, FR); Philippe Karoyan (Paris, FR); Helene Merle-Beral (Paris, FR)
Assignees:
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE PIERRE ET MARIE CURIE UPMC; UNIVERSITE PARIS DIDEROT-PARIS 7; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
Claims (1)
1. A soluble peptide of formula (II):
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 5, 2014
From: SUSIN, SANTOS; LAUNAY, PIERRE; KAROYAN, PHILIPPE; MERLE-BERAL, HELENE
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE PIERRE ET MARIE CURIE UPMC; UNIVERSITE PARIS DIDEROT-PARIS 7; UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Reel/Frame 034395/0851 →
Priority Claims (1)
EP 12305636
· Jun 6, 2012
· regional
Continuity (1)